Search is Powered by Google
Cancer / Oncology News

American Society Of Clinical Oncology To Issue Guidelines On How Physicians Should Discuss Cost Of Treatment Options With Patients

Main Category: Cancer / Oncology
Also Included In: Primary Care / General Practice;  Health Insurance / Medical Insurance
Article Date: 26 Mar 2008 - 12:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:4 stars

4 (3 votes)

Health Professional:not yet rated

Article Opinions: 2 posts

The American Society of Clinical Oncology later this year will release the first-ever guidelines for how oncologists can discuss cost-effective options for cancer treatment with their patients, AP/Long Island Newsday reports.

According to AP/Newsday, "Cancer sticker shock is hitting hard now" as cancer drugs that cost $100,000 are "no longer a rarity" and patients are living longer, requiring extended treatment periods. In addition, the cost of treating cancer is rising by 15% annually, according to Allen Lichter of ASCO. Affordable treatment options are a "particular issue" for patients with incurable forms of cancer who are looking for "both the longest possible survival and the best quality of life," AP/Newsday reports.

According to AP/Newsday, one of ASCO's suggestions will be for oncologists to consider the cost "essentially as another side effect" when choosing a treatment. In addition, Leonard Saltz of the Memorial Sloan-Kettering Cancer Center and other physicians at a meeting of the National Comprehensive Care Network advised ASCO to include chemotherapy costs in the treatment guidelines. According to Saltz, many physicians do not know the cost of certain treatments because they are not included in treatment standards. "If there's a need to spend it, let's talk about it," Saltz said, adding, "If we can do it just as well less expensively, I think doctors should know that and be able to make a decision" (Neergaard, AP/Long Island Newsday, 3/24).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Breast Cancer Cardiovascular GI Prostate Cancer Psychiatry Respiratory Learning Resources Migraine Urology
Asthma Bipolar Blood Pressure Breast Cancer (Patient) Heartburn

Sign up to receive newsletters / news alerts
MedReader RSS Reader




Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating Prostate Cancer Symptoms image Treating Prostate Cancer Symptoms

Many men will have advanced prostate cancer without any noticeable symptoms. Treatment for these patients is a bit different than for other patients with prostate cancer. Learn about these differences...

View more videos...

Add Your Advertisement Here